Vasoptic Medical gets $250K investment from Abell Foundation

Bye bye, ‘burbs. Vasoptic Medical is officially a city company now.
The medical device startup, which is making a device that allows primary-care doctors to give diabetes patients eye exams rather than making an extra trip to the eye doctor, completed its move from Columbia to Locust Point. The company’s new office is within Mindgrub’s climbing-wall-outfitted space near McHenry Row.
Earlier this summer, Vasoptic CEO M. Jason Brooke told us the move would help the company be closer to Johns Hopkins University and the University of Maryland School of Medicine, where the company is testing the device. He also believes the location will help in recruiting since it is close to other tech companies, amenities and interstate access. And let’s be honest: Mindgrub has a climbing wall.

Vasoptic is also riding into the city with new funding. The Abell Foundation invested $250,000 in the company, Brooke said. The money will help the company further develop and test the device.
“As a highly innovative company focused on improving the quality of accessible healthcare, Vasoptic is a great example of the type of company we want to see locate in Baltimore,” said Abell Foundation President Robert C. Embry, Jr. “The company is poised to significantly increase access to affordable, quality eye care and will contribute to the growth of Baltimore’s thriving tech industry.”